Загрузка...
Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
The influx of multiple novel therapeutic options in the mRCC field has brought a challenge for treatment sequencing in this disease. In the past few years, cabozantinib, nivolumab and the combination of lenvatinib and everolimus have been approved in the second-line setting. As there is no direct co...
Сохранить в:
| Опубликовано в: : | Kidney Cancer |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
IOS Press
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6179120/ https://ncbi.nlm.nih.gov/pubmed/30334001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/KCA-170006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|